대체적으로 정확하고 빠르게 인식되요
식사량이랑 대사량을 비교해주니 다이어트에 너무 도움이 되요! 얼만큼 더 먹어도 되는지 알 수 있어서 좋음.... 먹는 음식의 칼로리랑 단백질 비율까지 확인되다니🥹 뭘 더 챙겨먹어야되고, 뭘 더 줄여 먹어야하는지 아니까 확실히 다이어트에 도움이 되는거 같아요
추가로 수면부터 식사량, 할동량, 생리주기까지 한번에 모두 케어되니 이앱 저앱 옮겨다니며 입력하고 관리하지
않아도 되서 최고 좋습니다

This app provides one clear daily action tailored to your GLP-1 medication cycle, sleep, and diet. It learns from your feedback to personalize your plan and offers simple meal logging and wearable data syncing.
1.0.22
October 10, 2026
Fixed bugs and improved user experience
terofit monthly subscription.
TeroFit is a wellness and behavioral support app designed for people on GLP-1 injections. It provides a single, prioritized daily action based on your medication cycle, sleep, and diet, helping you execute your health goals without decision fatigue.
TeroFit learns from your feedback on whether you completed your daily action and how difficult it was. This information is used to shape tomorrow's plan, making it increasingly tailored to your individual needs and responses over time.
Yes, TeroFit Premium offers a 7-day free trial for both its monthly and yearly subscription plans. You can manage or cancel your subscription in your App Store account settings after purchase.
TeroFit Premium is available as an auto-renewing monthly subscription for $23.99 or an annual subscription for $134.99. Both plans include a 7-day free trial.
Your data is encrypted in transit, deletable upon request, and never sold. Meal photos are processed solely to estimate nutrition and are not used for other purposes.
TeroFit is supported on Apple Watch, iPhone, and iPod. It automatically syncs sleep, activity, and recovery data from your wearable devices.
The latest version of TeroFit is 1.0.22, and it was last updated on October 10, 2026. Updates typically occur to improve features and reliability.
No, TeroFit is a wellness and behavioral support app and does not diagnose, treat, or cure any condition, nor does it make dosing decisions or give medical advice. Always follow your healthcare provider's guidance.